Related Experiment Video
Updated: Sep 20, 2025

Iris Fixation via External Pentagram Suturing
Published on: May 5, 2022
[National protocol for diagnosis and care of congenital aniridia: Summary for the attending physician]
D Bremond-Gignac1, M Robert2, A Daruich1
1Service d'ophtalmologie, centre hospitalier universitaire Necker-Enfants Malades, AP-HP, université de Paris, 149, rue de Sèvres, 75015 Paris, France; Inserm 1138, T17, université de Paris, Paris, France; OPHTARA, Coordonnateur centre de maladies rares en ophtalmologie (CRMR), Filière Sensgene, centre hospitalier universitaire Necker-Enfants Malades, Paris, France.
Insights
Congenital aniridia, a rare genetic eye disease, involves iris absence and potential blindness. Early diagnosis and specialized care are crucial for managing ocular and systemic complications, improving patient quality of life.
Area of Science:
- Ophthalmology
- Genetics
- Pediatrics
Background:
- Congenital aniridia is a rare panocular disease characterized by the absence of iris tissue, often linked to PAX6 gene mutations.
- It is an autosomal dominant condition with high penetrance, affecting approximately 1 in 40,000 to 1 in 96,000 births.
- Ocular manifestations include corneal opacification, glaucoma, cataracts, and foveal hypoplasia, progressing with age.
Purpose of the Study:
- To outline the diagnostic and management protocols for congenital aniridia.
- To highlight the spectrum of ocular and systemic associations.
- To emphasize the importance of multidisciplinary care and rehabilitation for affected individuals.
Main Methods:
- Review of the national diagnostic and care protocol (PNDS) for congenital aniridia.
- Analysis of ocular and systemic manifestations based on clinical presentation and genetic factors.
- Description of management strategies, including medical, surgical, and medico-socio-educational interventions.
Main Results:
- Congenital aniridia presents with nystagmus, visual impairment, and photophobia in early infancy.
- Associated conditions include WAGR syndrome, Gillespie syndrome, and systemic issues like diabetes.
- Progressive ocular disorders necessitate proactive and responsive management.
Conclusions:
- Congenital aniridia requires specialized, lifelong care due to its progressive nature and potential for severe visual impairment.
- Ruling out syndromic forms and addressing systemic associations are critical.
- Rehabilitation and support services are essential to mitigate disability and enhance autonomy.
Abstract:
Congenital aniridia is a rare panocular disease defined by a national diagnostic and care protocol (PNDS) validated by the HAS. In most cases, it is due to an abnormality in the PAX6 gene, located at 11p13. Aniridia is a potentially blinding autosomal dominant disease with high penetrance. The prevalence varies from 1/40,000 births to 1/96,000 births. Approximately one third of cases are sporadic. Ocular involvement includes complete or partial absence of iris tissue, corneal opacification with neovascularization, glaucoma, cataract, foveal hypoplasia, optic disc hypoplasia and ptosis. These ocular disorders coexist to varying degrees and progress with age. Congenital aniridia manifests in the first months of life as nystagmus, visual impairment and photophobia. A syndromic form such as WAGR syndrome, WAGRO syndrome (due to the risk of renal Wilms tumor) or Gillespie syndrome (cerebellar ataxia) must be ruled out. Systemic associations may include diabetes, due to expression of the PAX6 gene in the pancreas, as well as other extraocular manifestations. Initial assessment is best carried out in a referral center specialized in rare ophthalmologic diseases, with annual follow-up. The management of progressive ocular involvement must be both proactive and responsive, with medical and surgical management. Visual impairment and photophobia result in disability, leading to difficulties in mobility, movement, communication, learning, fine motor skills, and autonomy, with consequences in personal, school, professional, socio-cultural and athletic life. Medico-socio-educational care involves a multidisciplinary team. Disability rehabilitation must be implemented to prevent and limit situations of handicap in activities of daily living, relying on the Commission for the Rights and Autonomy of People with Disabilities (CDAPH) within the Departmental House of People with Disabilities (MDPH). The general practitioner coordinates multidisciplinary medical and paramedical care.
More Related Videos
Related Concept Videos
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Photoreceptors and Visual Pathways

